A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes

Journal of Immunology

Volumn 156, Issue 6, 1996, Pages 2256-2263

  Grey, Shane T ^a,b   Hancock, Wayne W ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E; RETINOIC ACID; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD CLOTTING; ENDOTHELIUM; HEMOSTASIS; HUMAN; HUMAN CELL; IMMUNE SYSTEM; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MONOCYTES; PROSTAGLANDINS E; PROTEIN C; TETRADECANOYLPHORBOL ACETATE; THROMBOMODULIN; TRETINOIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029873131     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Broze, G. J., Jr., and J. P Miletich. 1994. Biochemistry and physiology of protein C, protein S, and thrombomodulin. In Hemostasis and Thrombosis, 3rd Ed. R. W. Colman, J. Hirsch, V. J. Marder, and E. W. Salzman, eds J. B. Lippincott Company, Philadelphia, PA, p. 259.
2. Esmon, C. T., and W. G. Owen. 1981. Identification of an endothelial cell co-factor for the thrombin-catalyzed activation of protein C. Proc. Natl. Acad. Sci. USA 78:2249.
3. Moore, K L., S. P. Andreoli, N. L Esmon, C. T. Esmon, and N. U. Bang 1987. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J. Clin Invest. 79:124.
4. Nawroth, P. P., D. A. Handley, C. T. Esmon, and D. M. Stern. 1986. Interleukin 1 induces endothelial cell procoagutant while suppressing cell-surface anticoagulant activity. Proc Natl Acad. Sci USA 83:3460.
5. Nawroth, P. P., and D. M. Stern 1986. Modulation of hemostatic properties by tumor necrosis factor. J. Exp. Med. 163.740.
6. Moore, K. L., N. L. Esmon, and C. T. Esmon 1989. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells. Blood 73:159.
7. Pober, J. S., and R. S. Cotran. 1991. The role of endothelial cells in inflammation Transplantation 50:537.
8. Hirokawa, K , and N. Aoki 1991. Regulatory mechanisms for thrombomodulin expression in human umbilical vein endothelial cells in vitro. J. Cell Physiol. 147:157.
9. Soff, G A., R. W Jackman, and R D. Rosenberg 1991. Expression of thrombomodulin by smooth muscle cells in culture: different effects of tumor necrosis factor and cyclic adenosine monophosphate on thrombomodulin expression by endothelial cells and smooth muscle cells in culture. Blood 77:515.
10. Horie, S., K. Kizaki, and M. Kazama. 1992. Retinoic acid stimulates expression of thrombomodulin, a cell surface anticoagulant glycoprotein, on human endothelial cells, differences between up-regulation of thrombomodulin by retinoic acid and cyclic AMP. Biochem J 281:149.
11. Weiler-Guettler, H , K. Yu, G. Soff, L. J. Gudas, and R. D. Rosenberg. 1992. Thrombomodulin gene regulation by cAMP and retinoic acid in F9 embryonal carcinoma cells. Proc. Natl Acad. Sci. USA 89:2155
12. Dittman, W. A., S. C. Nelson, P. K Greer, E. T. Horton, M L. Palomba, and S S. McCachren 1994. Characterization of thrombomodulin expression in response to retinoic acid and identification of a retinoic acid response element in the human thrombomodulin gene J. Biol. Chem. 269:16925.
13. Miyake, S., S. Ohdama, R. Tazawa, and N. Aoki. 1992. Retinoic acid prevents cytokine-induced suppression of thrombomodulin expression on the surface of human umbilical vascular endothelial cells in vitro. Thromb. Res. 68:483
14. Ishii, H., S Horie, K. Kizaki, and M. Kazama. 1992. Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor. Blood 80:2556
15. McCachren, S. S., J. Diggs, J. B. Weinberg, and W. A. Dittman. 1991. Thrombomodulin expression by human blood monocytes and by human synovial tissue-lining macrophages. Blood 78:3128.
16. Koyama, T., S. Hirosawa, N. Kawamata, S. Tohda, and N. Aoki. 1994. All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells. Blood 84:3001.
17. Grey, S. T , A. Tsuchida, H. Hau, C L. Orthner, H H Salem, and W W Hancock. 1994 Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-γ, or phorbol ester. J. Immunol. 153:3664.
18. Hancock, W. W., S. T. Grey, H. Hau, H. Akalin, C. Orthner, M. H Sayegh, and H. H. Salem 1995. Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signalling and monocyte-dependent proliferative responses. Transplantation 60:1525.
19. Teasdale, M. S , C H. Bird, and P. Bird. 1994. Internalization of the anticoagulant thrombomodulin is constitutive and does not require a signal in the cytoplasmic domain. Immunol. Cell. Biol. 72:480.
20. Tsuchida, A., H. Salem, N. M. Thomson, and W W Hancock. 1992 Tumor necrosis factor production during human renal allograft rejection is associated with depression of plasma protein C and free protein S levels and decreased intragraft thrombomodulin expression. J. Exp. Med. 175:81.
21. Salom, R. N., J, A. Maguire, D. Esmore, and W. W. Hancock. 1995 Endothelial cell activation and cytokine expression during acute human cardiac allograft rejection. Transplant. Proc. 27.2164.
22. Hanson, S R., J. H. Griffin, L. A Harker, A. B Kelly, C. T. Esmon, and A. Grober. 1993. Antithrombotic effects of thrombin-induced activation of endogenous protein-C in primates. J. Clin. Invest 92:2003
23. Taylor, F. B , Jr., A Chang, C. T. Esmon, A. D'Angelo, S. Vigano-D'Angelo, and K. E Blick. 1987. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J. Clin Invest. 79:918.
24. Hancock, W. W., A. Tsuchida, H Hau, N. M. Thomson, and H. H. Salem. 1992 The anticoagulants protein-C and protein-S display potent anti-inflammatory and immunosuppressive effects relevant to transplant biology and therapy. Transplant Proc. 24:2302.
25. Grinnell, B. W., R B. Hermann, and S. B. Yan. 1994. Human protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide. Glycobiology 4:221.
26. Conway, E. M., B Nowakowski, and M. Steinermosonyi. 1992. Human neutrophils synthesize thrombomodulin that does not promote thrombin-dependent protem-C activation Blood 80:1254.
27. Compeau, C. G., J. Ma, K. N. Decampos, T. K. Waddell, G. F. Brisseau, A. S. Slutsky, and O. D. Rotstein. 1994. In situ ischemia and hypoxia enhance alveolar macrophage tissue factor expression. Am. J. Respir. Cell Mol. Biol. 11:446.
28. Perez, R. L., and J. Roman. 1995. Fibrin enhances the expression of IL-1-β by human peripheral blood mononuclear cells: implications in pulmonary inflammation J. Immunol. 154.1879.
29. Conway, E. M. L Liu, B Nowakowski, M. M. Steiner, and R. W. Jackman. 1994. Heat shock of vascular endothelial cells induces an up-regulatory transcriptional response of the thrombomodulin gene that is delayed in onset and does not attenuate. J. Biol. Chem. 269:22804
30. Hirokawa, K., and N. Aoki. 1991. Regulatory mechanisms for thrombomodulin expression in human umbilical vein endothelial cells in vitro. J. Cell Physiol. 147:157.
31. Kitchens, R L., R J. Ulevitch, and R. S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhabiting LPS uptake by a CD14-mediated pathway. J. Exp. Med 176: 485.
32. Knudsen, P. J., C A. Dinarello, and T. B. Strom 1986. Prostaglandins posttranslationally inhibit monocyte expression of IL-1 activity by increasing intracellular cyclic adenosine monophosphate J. Immunol. 137.3189.
33. Hancock, W. W , M. E. Pleau, and L. Kobzik. 1988. Recombinant granulocyte-macrophage colony-stimulating factor down-regulates expression of IL-2 receptors on human mononuclear phagocytes by induction of prostaglandin-E J. Immunol. 140:3021.
34. Kovacs, E. J. 1994. Control of IL-1 and TNF-α production at the level of second messenger pathways. In Cytokines and Inflammation. E. S Kimball, ed. CRC Press, Boston, MA, p.90.
35. Koga, S., S. Morris, S. Ogawa, H. Liao, J P. Bilezikian, G. Chen, W. J. Thompson, T. Ashikaga, J. Brett, D M. Stern, and D. J Pinsky. 1995. TNF modulates endothelial properties by decreasing cAMP Am. J. Physiol. Cell. Physiol. 37. C1104.
36. Fukudome, K , and C. T. Esmon. 1994. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor J. Biol. Chem. 269:26486.